Application of CXCR3 expression in T cells for early diagnostics and prevention of malignant mesothelioma
| Project/Area Number |
22700933
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Cancer epidemiology and prevention
|
|---|
| Research Institution | Okayama University (2011)
Kawasaki Medical School (2010) |
|---|
Principal Investigator |
MAEDA Megumi 岡山大学, 大学院・自然科学研究科, 助教 (20434988)
|
|---|
| Project Period (FY) |
2010 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2010: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | アスベスト / 悪性中皮腫 / 胸膜プラーク / 抗腫瘍免疫 / ケモカインレセプター / サイトカイン / 石綿 / CD4^+ T細胞 / 中皮腫 / ケモカインレセプターCXCR3 / IFN-γ / Th17細胞 / IL-17 / RORγt / IFN-_γ |
|---|
| Research Abstract |
The expression of CXCR3 in peripheral CD4+ T cells was decreased in asbestos-related patients with pleural plaque and malignant mesothelioma, and IFN-γexpression was impaired in only patients with malignant mesothelioma. Additionally, in vitro study showed that IL-17 expression was enhanced while CXCR3 and IFN-γexpression were suppressed by chronic exposure of CD4+ T cells to asbestos. These results suggested that chronic exposure to asbestos might induce impairment of antitumor immune function and promotion of tumor proliferation.
|
Report
(3 results)
Research Products
(49 results)
-
-
-
[Journal Article] Reduction of CXC chemokine receptor 3 in an in vitro model of continuous exposure to asbestos in a human T-cell line, MT-22011
Author(s)
Maeda M, Nishimura Y, Hayashi H, Kumagai N, Chen Y, Murakami S, Miura Y, Hiratsuka J, Kishimoto T, Otsuki T
-
Journal Title
Am J Respir Cell Mol Biol
Volume: 45
Pages: 470-479
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
